MAM
GSK icon

Meeder Asset Management’s GSK GSK Stock Holding History

Meeder Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$3K – 1282
2022
Q3 		$3K Sell
100
-203
-67% -$7.69K ﹤0.01% 1710
2022
Q2 		$16K Buy
303
+137
+83% +$7.56K ﹤0.01% 1216
2022
Q1 		$9K Buy
166
+160
+2,667% +$8.69K ﹤0.01% 1578
2021
Q4 		$0 Sell
6
-25
-81% -$1.3K ﹤0.01% 1655
2021
Q3 		$1K Buy
31
+17
+121% +$854 ﹤0.01% 2322
2021
Q2 		$1K Sell
14
-446
-97% -$21.4K ﹤0.01% 2342
2021
Q1 		$21K Buy
460
+446
+3,186% +$20.2K ﹤0.01% 1390
2020
Q4 		$1K Hold
14
– – ﹤0.01% 1655
2020
Q3 		$1K Sell
14
-140
-91% -$7.01K ﹤0.01% 1979
2020
Q2 		$8K Hold
154
– – ﹤0.01% 1387
2020
Q1 		$7K Hold
154
– – ﹤0.01% 1654
2019
Q4 		$9K Buy
+154
New +$8.57K ﹤0.01% 1588

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Meeder Asset Management's GSK Position: Q4 2022 in Review

Meeder Asset Management sold out of GSK (GSK) in Q4 2022, closing a stake of 100 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in GSK in Q4 2019 and held it in 12 quarters. The position peaked at $21K in Q1 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Meeder Asset Management reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 100 GSK shares in Q4 2022, an estimated $3K.
  • Meeder Asset Management first reported a position in GSK in Q4 2019 and held it in 12 quarters.
  • Meeder Asset Management's GSK position peaked at $21K in Q1 2021.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.